Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2006, p. 2316-2322, Vol. 50, No. 7
0066-4804/06/$08.00+0 doi:10.1128/AAC.01488-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Biomedical Sciences, Dstl Porton Down, Salisbury, Wiltshire SP4 0JQ, United Kingdom
Received 18 November 2005/ Returned for modification 3 February 2006/ Accepted 29 March 2006
In this paper we report on the susceptibilities of a range of Bacillus species to the human antimicrobial peptide LL-37. B. subtilis showed a low level of resistance to killing by LL-37 (50% growth-inhibitory concentration [GI50], 1 µg/ml). B. cereus and B. thuringiensis showed intermediate levels of resistance to killing (GI50s, 33 µg/ml and 37 µg/ml, respectively). B. anthracis showed the highest level of resistance (GI50s, 40 to 66 µg/ml). The degradation of LL-37 by B. anthracis culture supernatant was blocked by the metalloprotease inhibitors EDTA and 1,10-phenanthroline, and the gene encoding the protease responsible for LL-37 degradation was not plasmid borne. Our findings suggest that alongside the classical plasmid-based virulence determinants, extracellular metalloproteases of B. anthracis may play a role in survival in the host.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |